AMOXICILLIN; VONOPRAZAN FUMARATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for amoxicillin; vonoprazan fumarate and what is the scope of freedom to operate?
Amoxicillin; vonoprazan fumarate
is the generic ingredient in one branded drug marketed by Phathom and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Amoxicillin; vonoprazan fumarate has one hundred and three patent family members in forty-three countries.
One supplier is listed for this compound.
Summary for AMOXICILLIN; VONOPRAZAN FUMARATE
International Patents: | 103 |
US Patents: | 2 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 7 |
DailyMed Link: | AMOXICILLIN; VONOPRAZAN FUMARATE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for AMOXICILLIN; VONOPRAZAN FUMARATE
Generic Entry Date for AMOXICILLIN; VONOPRAZAN FUMARATE*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW Dosage:
CAPSULE, TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for AMOXICILLIN; VONOPRAZAN FUMARATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 |
The First Affiliated Hospital of Nanchang University | Phase 4 |
Shunde Hospital of Southern Medical University | Phase 4 |
US Patents and Regulatory Information for AMOXICILLIN; VONOPRAZAN FUMARATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phathom | VOQUEZNA DUAL PAK | amoxicillin; vonoprazan fumarate | CAPSULE, TABLET;ORAL | 215153-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Phathom | VOQUEZNA DUAL PAK | amoxicillin; vonoprazan fumarate | CAPSULE, TABLET;ORAL | 215153-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Phathom | VOQUEZNA DUAL PAK | amoxicillin; vonoprazan fumarate | CAPSULE, TABLET;ORAL | 215153-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Phathom | VOQUEZNA DUAL PAK | amoxicillin; vonoprazan fumarate | CAPSULE, TABLET;ORAL | 215153-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for AMOXICILLIN; VONOPRAZAN FUMARATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Singapore | 186685 | PHARMACEUTICAL COMPOSITION | ⤷ Try a Trial |
Montenegro | 00610 | 1 -HETEROCIKLILSULFONIL, 2 -AMINOMETIL, 5- (HETERO-) ARIL SUPSTITUISAN 1-H-PIROL DERIVATI KAO INHIBITORI LUČENJA KISELINE (1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS) | ⤷ Try a Trial |
Croatia | P20110473 | ⤷ Try a Trial | |
Ukraine | 103332 | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ НЕПЕПТИДНЫЙ АКТИВНЫЙ АГЕНТ С ПЕРВИЧНОЙ ИЛИ ВТОРИЧНОЙ АМИНОГРУППОЙ;ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ НЕПЕПТИДНИЙ АКТИВНИЙ АГЕНТ З ПЕРВИННОЮ АБО ВТОРИННОЮ АМІНОГРУПОЮ (PHARMACEUTICAL COMPOSITION CONTAINING A NONPEPTIDIC ACTIVE AGENT HAVING A PRIMARY OR SECONDARY AMINO GROUP) | ⤷ Try a Trial |
Morocco | 32556 | تركيب صيدلاني | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |